Solara Active Pharma Sciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 2,487.3 million compared to INR 3,947.5 million a year ago. Revenue was INR 2,491.8 million compared to INR 4,019.2 million a year ago. Net loss was INR 2,753.4 million compared to net income of INR 0.43 million a year ago. Basic loss per share from continuing operations was INR 76.49. Diluted loss per share from continuing operations was INR 76.49 compared to earnings of INR 0.12 a year ago.

For the nine months, the company reported sales was INR 10,262.8 million compared to INR 10,631.9 million a year ago. Revenue was INR 10,299.5 million compared to INR 10,810.6 million a year ago. Net loss was INR 3,120.5 million compared to INR 259.4 million a year ago. Basic loss per share from continuing operations was INR 86.69. Diluted loss per share from continuing operations was INR 86.69 compared to INR 7.21 a year ago.